MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Invitae Corporation DIO Ratio 2011-2025 | NVTA
Annual DIO Ratio Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 126 | 124 | 35.6 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 126 | 35.6 | 95.2 |
Quarterly DIO Ratio Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.6 | 20.8 | 25.5 | - | 30.8 | 38.3 | 36.2 | 30.4 | 31.5 | 31 | 37.9 | 42.8 | 62.7 | 68 | 43.7 | 16.5 | 18.8 | 21.5 | 32 | 35.8 | 37 | 37 | 34.6 | 14.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 68 | 14.4 | 33.5 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Exact Sciences Corporation
EXAS
|
240 | $ 101.5 | - | $ 18.8 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 16.66 | 5.75 % | $ 179 M |  China |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
245 | $ 1.57 | -3.4 % | $ 2 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
48.7 | $ 38.42 | -0.54 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
165 | $ 11.98 | 0.76 % | $ 340 M |  Israel |
 |
DexCom
DXCM
|
119 | $ 65.76 | -1.79 % | $ 25.4 B | USA |
 |
Danaher Corporation
DHR
|
92.9 | $ 226.02 | -0.21 % | $ 165 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 26.95 | -0.7 % | $ 815 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 19.75 | -3.94 % | $ 1.06 B | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
304 | $ 0.31 | -9.72 % | $ 9.1 M | USA |
 |
Guardant Health
GH
|
78.4 | $ 103.49 | 1.39 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
137 | $ 134.29 | -0.43 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 196.54 | 1.84 % | $ 10.1 B | USA |
 |
Quotient Limited
QTNT
|
386 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 183.1 | 0.32 % | $ 20.3 B | USA |
 |
Mettler-Toledo International
MTD
|
79 | $ 1 407.75 | 0.99 % | $ 29.9 B | Schweiz |
 |
Myriad Genetics
MYGN
|
35.8 | $ 6.97 | -3.33 % | $ 631 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.8 | $ 260.62 | -1.35 % | $ 21.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 182.8 | -2.03 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
91.6 | $ 699.0 | -0.74 % | $ 57.6 B | USA |
 |
NeoGenomics
NEO
|
25.1 | $ 12.06 | 1.73 % | $ 1.53 B | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 6.79 | -1.09 % | $ 1.47 B | USA |
 |
Lantheus Holdings
LNTH
|
44.2 | $ 67.14 | 0.78 % | $ 4.65 B | USA |
 |
Agilent Technologies
A
|
97.1 | $ 140.44 | 0.56 % | $ 42.7 B | USA |
 |
Biomerica
BMRA
|
147 | $ 2.43 | -5.89 % | $ 5.58 M | USA |
 |
Bioventus
BVS
|
175 | $ 7.53 | -0.26 % | $ 472 M | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | Israel |
 |
Pacific Biosciences of California
PACB
|
132 | $ 2.11 | -0.47 % | $ 535 M | USA |